Found: 6
Select item for more details and to access through your institution.
Effects of the β-agonist, isoprenaline, on the down-regulation, functional responsiveness and trafficking of β<sub>2</sub>-adrenergic receptors with N-terminal polymorphisms.
- Published in:
- Cell Biology International, 2012, v. 36, n. 12, p. 1171, doi. 10.1042/CBI20120134
- By:
- Publication type:
- Article
Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity.
- Published in:
- PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0021917
- By:
- Publication type:
- Article
481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
384 Motives for kratom self-medication: contents of public comments solicited by the FDA.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Effects of prenatal opioid exposure and early life adversity on opioid‐induced antinociception.
- Published in:
- FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.R2388
- By:
- Publication type:
- Article
Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1123261
- By:
- Publication type:
- Article